378
V.V. Kollerov et al. / Steroids 78 (2013) 370–378
[15] Kulprecha S, Ueda T, Nichira T, Yochida T, Tagushi H. Optimum conditions for
Under the optimized conditions, the yield of UDCA reached
ursodeoxycholic acid production from lithocholic acid by Fusarium equiseti M-
41. Appl Environ Microbiol 1985;49:338–44.
[16] Hayakawa S. Microbial transformation of bile acids. A unified scheme for bile
ꢂ90% at a LCA loading of 1 g/L, while an 8-fold increase of substrate
concentration resulted in 4.8 g/L UDCA at one batch. The results are
considerably more positive than those previously published and
they might be suitable for preparative-scale exploitation of the se-
lected fungal strains for UDCA production.
acid degradation, and hydroxylation of bile acids.
1982;22:309–26.
Z Allg Mikrobiol
[17] Sawada H, Kulprecha S, Nilubol N, Yoshida T, Kinoshita S, Taguchi H. Microbial
production of ursodeoxycholic acid from lithocholic acid by Fusarium equiseti
M41. Appl Environ Microbiol 1982;44:1249–52.
[18] Li S, Fa Y. Screening of strains producing ursodeoxycholic acid from lithocholic
acid and identification of product. Acta Microbiol Sinica 1995;35:197–203.
[19] Sawada H, Taguchi H. Method for production of ursodeoxycholic acid by
means of microbial transformation. US Patent 4,579,819; 1986.
[20] Okamura A, Matsui H. Bile acid converting microorganism and process for
preparing bile acid. US Patent 5,989,855; 1999.
Acknowledgments
´
The authors are grateful to Dr. K.K. Pivnicki (Zelinskis Institute
of Organic chemistry, Russian Academy of Sciences) for the perfor-
mance and interpretation of 1H NMR analysis. Dr. Giovanni Fronza
(ICRM-CNR) is kindly acknowledged for his support in character-
ization of by-products. The Landau Network-Centro Volta is grate-
fully acknowledged for a fellowship to V. V. K. The work was partly
supported by Russian Foundation for Basic Research (RFBR), Grant
no 12-04-31253.
[21] Lobastova TG, Gulevskaya SA, Sukhodolskaya GV, Turchin KV, Donova MV.
Screening of mycelial fungi for
7a- and 7b-hydroxylase activity towards
dehydroepiandrosterone. Biocatal Biotransform 2007;25:434–42.
[22] Donova MV. Steroid bioconversion by actinobacteria. Pushchino: ONTI PSC
RAS; 2009.
[23] Jork H, Funk W, Fischer W, Wimmer H. Thin-layer chromatography. Reagents
and detection methods. Weinheim: FRG; 1990.
[24] Macdonald IA. Detection of bile acids with Komarowsky´reagent and group
specific dehydrogenases. J Chromatogr 1977;136:348–52.
Appendix A. Supplementary data
[25] Dangate PS, Salunke CL, Akamanchi KG. Regioselective oxidation of cholic acid
and its 7b epimer by using o-iodoxybenzoic acid. Steroids 2011;76:1397–9.
[26] Bortolini O, Fantin G, Fogagnolo M, Forlani R, Maietti S, Pedrini P. Improved
enantioselectivity in the epoxidation of cinnamic acid derivatives with
dioxiranes from keto bile acids. J Org Chem 2002;67:5802–6.
Supplementary data associated with this article can be found, in
[27] Riva S, Bovara R, Zetta L, Pasta P, Ottolina G, Carrea G. Enzymatic a/b inversion
of C-3 hydroxyl of bile acids and study of the effects of organic solvents on
reaction rates. J Org Chem 1988;53:88–92.
[28] Lobastova TG, Gulevskaya SA, Sukhodolskaya GV, Donova MV. Dihydroxylation
References
of dehydroepiandrosterone in positions 7
Biochem Microbiol 2009;45:617–22.
a and 15a by mycelial fungi. Appl
[1] Alvarez M, Jover A, Carrazana J, Meijide F, Soto VH. Vazquez Tato J. Crystal
[29] Edenharder R, Schneider J. 12b-Dehydrogenation of bile acids by Clostridium
paraputrificum, C. tertium, and C. difficile and epimerization at carbon-12 of
structure of chenodeoxycholic acid, ursodeoxycholic acid and their two 3b,7
and 3b,7b-dihydroxy epimers. Steroids 2007;72:535–44.
a-
deoxycholic acid by cocultivation with 12
a-dehydrogenating Eubacterium
[2] Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid «mechanisms of action
and clinical use in hepatobiliary disorders. World J Hepatol 2001;35:134–46.
[3] Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology,
pathobiology, and therapeutics cell. Mol Life Sci 2008;65:2461–83.
[4] Prabha V, Ohri M. Bacterial transformation of bile acids. World J Microbiol
Biotechnol 2006;22:191–6.
lentum. Appl Environ Microbiol 1985;49:964–8.
[30] Alan F. Hofmann l, Karol J. Bile acid solubility and precipitation in vitro and
in vivo: the role of conjugation, pH, and Ca ions. J Lipid Res 1992;33:617–26.
[31] Kulprecha S, Nihira T, Yamada K, Yoshida T, Nilubol N, Taguchi H.
Transformation of lithocholic acid to a new bile acid, 3a,15b-dihydroxy-5b-
cholanic acid by Cunnighamella blakesleeana ST-22. Appl Microbiol Biotechnol
1985;22:211–6.
[5] Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS
Microbiol Rev 2005;29:625–51.
[32] Wang Z, Zhao F, Hao X, Chen D, Li D. Microbial transformation of hydrophobic
compound in cloud point system. J Mol Catal B: Enzym 2004;27:147–53.
[33] Avramova T, Spassova D, Mutafov S, Momchilova S, Boyadjieva L, Damyanova
[6] Mahato S, Mukherjee E, Banerjee S. Advances in microbial biotechnology of
bile acids. Biotech Adv 1994;12:357–61.
[7] Sharma R, Prichard D, Majer F, Byrne AM, Kelleher D, Long A, et al.
Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators. J
Med Chem 2011;54:122–30.
[8] Bortolini O, Medici A, Poli S. Biotransformations on steroid nucleus of bile
acids. Steroids 1997;62:564–77.
[9] Ikegami CI, Matsusaki Y. Ursodeoxycholic acid. Mechanism of action and novel
clinical applications. Hepatol Res 2008;38:123–31.
[10] Williams CI, Shaffer EA. Gallstone disease: current therapeutic practice. Curr
Treat Options Gastroenterol 2008;48:692–4.
[11] Philipp B. Bacterial degradation of bile salts. Appl Microbiol Biotechnol
2011;89:903–15.
[12] Donova M, Egorova O. Microbial steroid transformations: current state and
prospects. Appl Microbiol Biotechnol 2012;94:1423–47.
[13] Carlstroem K, Kirk DN, Sjoevall J. Microbial synthesis of 1b- and 15b-
hydroxylated bile acids. J Lipid Res 1981;22:1225–34.
B, Angelova B. Effect of Tween 80 on 9a-steroid hydroxylating activity and
ultrastructural characteristics of Rhodococcus sp. cells. World
J Microbiol
Biotechnol 2010;26:1009–14.
[34] El Refai HA, Abd-elslam IS. Enhancement of b-sitosterol bioconversion by
Fusarium solani using aqueous-organic solvent system. Aust J Basic Appl Sci
2010;4:4107–12.
[35] Macdonald IA, Forrest TP, Costain GA, Rao BG. Identification of
7a,12a-
dihydroxy-3-oxocholanoic acid as the major degradation product from cholic
by C. perfringens. J Steroid Biochem 1978;9:353–8.
[36] Kimura H, Okamura A. Kawaide H, Yamaura T. Oxidation of bile acids with
Bacillus. European Patent 518,661; 1992.
[37] Shigeru U, Masayuki O, Shigeyuki I, Masatake O. Steady-state kinetic
properties of
3a-hydroxysteroid dehydrogenase from Pseudomonas sp. B-
0831: steroid substrate specificity and nucleotide cofactor dependency. J Biol
Macromol 2004;4:23–8.
[14] Hayakawa S, Yao K, Lijima M, Sasaki K. Hydroxylation of litchoholic acid using
the fungus Helicostylum piriforme. J Chem Soc Chem Commun 1980;3:84–5.